Inventor
WEI EDWARD T
US31 patents
⚠️ This page may combine multiple inventors who share the name “WEI EDWARD T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV CALIFORNIA
15 patentsUS5177060AJan 5, 1993
Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
UNIV CALIFORNIA21 citations92
US5137871AAug 11, 1992
Treatment to reduce edema for brain and musculature injuries
UNIV CALIFORNIA25 citations92
US4801612AJan 31, 1989
Method of inhibiting inflammatory response
UNIV CALIFORNIA62 citations91
US5482930AJan 9, 1996
Anti-inflammatory composition and method with des-Tyr dynorphin and analogues
UNIV CALIFORNIA25 citations90
US5480869AJan 2, 1996
Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues
UNIV CALIFORNIA45 citations90
US5869450AFeb 9, 1999
Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
UNIV CALIFORNIA39 citations87
US5306710AApr 26, 1994
Method for treating endotoxin shock with CRF
UNIV CALIFORNIA17 citations82
US5488033AJan 30, 1996
Treatment to reduce edema
UNIV CALIFORNIA8 citations74
US5374621ADec 20, 1994
Neurotensin method for inhibiting vascular leakage
UNIV CALIFORNIA11 citations74
US4481191ANov 6, 1984
Method for controlling blood pressure
UNIV CALIFORNIA14 citations73
US6953779B2Oct 11, 2005
Melanocortin receptor antagonists and modulations of melanocortin receptor activity
UNIV CALIFORNIA7 citations71
US6319900B1Nov 20, 2001
Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
UNIV CALIFORNIA8 citations68
US6849600B2Feb 1, 2005
Corticotropin-releasing hormone analogs
UNIV CALIFORNIA4 citations54
US5631226AMay 20, 1997
Treatment to reduce edema
UNIV CALIFORNIA0 citations52
US6803359B2Oct 12, 2004
Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
UNIV CALIFORNIA0 citations47
WEI EDWARD T
8 patentsUS10195217B2Feb 5, 2019
Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort
WEI EDWARD T7 citations83
US9642868B2May 9, 2017
Topical agents for the treatment of sensory discomfort in the nasal cavity
WEI EDWARD T9 citations83
US9895382B2Feb 20, 2018
Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort
WEI EDWARD T6 citations72
US8529915B2Sep 10, 2013
(R)-(-)-1,2-propanediol compositions and methods
WEI EDWARD T4 citations62
US8426463B2Apr 23, 2013
[((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
WEI EDWARD T0 citations51
US7417048B2Aug 26, 2008
Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets
WEI EDWARD T1 citations51
US7169377B2Jan 30, 2007
Radioligands for the TRP-M8 receptor and methods therewith
WEI EDWARD T1 citations51
US9822136B2Nov 21, 2017
Chemical inhibitors of sebocyte function
WEI EDWARD T0 citations49
(unassigned)
5 patentsUS6919348B2Jul 19, 2005
Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
35 citations92
US6228840B1May 8, 2001
Melanocortin receptor antagonists and modulations of melanocortin receptor activity
29 citations88
US6893626B2May 17, 2005
Compositions for TRP-M8 binding and radioreceptor methods therewith
13 citations84
US6743801B2Jun 1, 2004
1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for pain and inflammation
6 citations73
US6933301B2Aug 23, 2005
1,2,3,6-tetrahydropyrimidine-2-one compositions, articles and therapeutic methods for upper airway breathing disorders
2 citations62
IVIEW THERAPEUTICS INC
3 patentsUS11406649B2Aug 9, 2022
Treatment of upper aerodigestive tract disorders and cough
IVIEW THERAPEUTICS INC3 citations72
US12029743B2Jul 9, 2024
Di-isopropyl-phosphinoyl-alkanes as topical agents for the treatment of sensory discomfort
IVIEW THERAPEUTICS INC0 citations61
US11684628B2Jun 27, 2023
Di-isopropyl-phosphinoyl-alkanes (DAPA) compounds as topical agents for the treatment of sensory discomfort
IVIEW THERAPEUTICS INC0 citations61